Quris Was Chosen To Participate In AstraZeneca's BeyondBio SCALE Program
December 18, 2022
Six startup companies have been selected to participate in the BeyondBio SCALE program led by the British-Swedish global pharmaceutical giant AstraZeneca, the international consulting giant Accenture, the cloud infrastructure leader AWS and Clalit - the largest healthcare organization in Israel.
This will be the third cohort of the program since AstraZeneca BeyondBio Hub was launched, following an agreement between the pharma giant and the Israeli government.
The program is expected to last about nine months with the aim of helping Israeli startups in the fields of digital health and artificial intelligence to successfully navigate the challenging journey from startup to scaleup. The program focuses on providing expert support to the startups, with the aim of helping them develop their markets and deploy their solutions both in the healthcare system in Israel, and on a global scale.
See more on Calcalist